Arthneeti
Fundraise / allotmentFiled on BSE ·

Jubilant Pharmova approves issuance of up to ₹800 crore NCDs on private placement

Jubilant Pharmova Ltd · Pharmaceuticals & Biotechnology

What the filing says

  • Board approved issuance of up to 80,000 non-convertible debentures (NCDs) of ₹1,00,000 face value each, totaling ₹800 crore, in one or more tranches
  • NCDs to be secured/unsecured, listed, rated, redeemable, and transferable, with tenure up to five years and coupon to be decided via bidding
  • Members' approval sought via postal ballot for issuance of debt securities up to ₹2,500 crore outstanding over one year from special resolution date

Original filing

Announcement under Regulation 30 (LODR)-Raising of Funds

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies
Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Jubilant Pharmova Ltd

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.